Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate

Carcinogenesis

Volumn 25, Issue 6, 2004, Pages 1011-1014

  Homma, Yukio ^a   Kondo, Yasushi ^a   Kaneko, Masashi ^a   Kitamura, Tadaichi ^a   Nyou, Wei Tak ^b   Yanagisawa, Makoto ^b   Yamamoto, Yorihiro ^b   Kakizoe, Tadao ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; CHOLESTEROL; LIPID; UBIQUINONE; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CHOLESTEROL DIET; CHOLESTEROL INTAKE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE MODEL; FAT INTAKE; FOOD INTAKE; HISTOPATHOLOGY; LIPID PEROXIDATION; MALE; MEDICAL ASSESSMENT; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROSTATE HYPERTROPHY; RAT; ANIMAL; CELL TRANSFORMATION; ORGAN SIZE; PATHOLOGY; PROSTATE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHOLESTEROL, DIETARY; MALE; ORGAN SIZE; OXIDATIVE STRESS; PROSTATE; RATS;

EID: 3042730692     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh105     Document Type: Article

References (41)

1. Muir,C.S., Nectoux,J. and Staszewski,J. (1991) The epidemiology of prostatic cancer. Geographical distribution and time-trends. Acta Oncol., 30, 133-140.
2. Breslow,N., Chan,C.W., Dhom,G. et al. (1977) Latent carcinoma of prostate at autopsy in seven areas. The International Agency for Research on Cancer, Lyon, France. Int. J. Cancer, 20, 680-688.
3. Yatani,R., Kusano,I., Shiraishi,T., Hayashi,T. and Stemmermann,G.N. (1989) Latent prostatic carcinoma: pathological and epidemiological aspects. Jpn. J. Clin. Oncol., 19, 319-326.
4. Shimizu,H., Ross,R.K., Bernstein,L., Yatani,R., Henderson,B.E. and Mack,T.M. (1991) Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br. J. Cancer, 63, 963-966.
5. Cook,L.S., Goldoft,M., Schwartz,S.M. and Weiss,N.S. (1999) Incidence of adenocarcinoma of the prostate in Asian immigrants to the United States and their descendants. J. Urol., 161, 152-155.
6. Giles,G. and Ireland,P. (1997) Diet, nutrition and prostate cancer. Int. J. Cancer, (suppl.), 13-17.
7. Shirai,T., Asamoto,M., Takahashi,S. and Imaida,K. (2002) Diet and prostate cancer. Toxicology, 181/182, 89-94.
8. Giovannucci,E., Rimm,E.B., Colditz,G.A., Stampfer,M.J., Ascherio,A., Chute,C.C. and Willett,W.C. (1993) A prospective study of dietary fat and risk of prostate cancer. J. Natl Cancer Inst., 85, 1571-1579.
9. Gann,P.H., Hennekens,C.H., Sacks,F.M., Grodstein,F., Giovannucci,E.L. and Stampfer,M.J. (1994) Prospective study of plasma fatty acids and risk of prostate cancer. J. Natl Cancer Inst., 86, 281-286.
10. Bairati,I., Meyer,F., Fradet,Y. and Moore,L. (1998) Dietary fat and advanced prostate cancer. J. Urol., 159, 1271-1275.
11. Fleshner,N.E. and Kucuk,O. (2001) Antioxidant dietary supplements: rationale and current status as chemopreventive agents for prostate cancer. Urology, 57, 90-94.
12. Vaca,C.E., Wilhelm,J. and Harms-Ringdahl,M. (1988) Interaction of lipid peroxidation products with DNA. A review. Mutat. Res., 195, 137-149.
13. Liu,X.H., Yao,S., Kirschenbaum,A. and Levine,A.C. (1998) NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res., 58, 4245-4249.
14. Rose,D.P. and Connolly,J.M. (1991) Effects of fatty acids and eicosanoid synthesis inhibitors on the growth of two human prostate cancer cell lines. Prostate, 18, 243-254.
15. Yoshizawa,K., Willett,W.C., Morris,S.J., Stampfer,M.J., Spiegelman,D., Rimm,E.B. and Giovannucci,E. (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J. Natl Cancer Inst., 90, 1219-1224.
16. Fleshner,N., Fair,W.R., Huryk,R. and Heston,W.D. (1999) Vitamin E inhibits the high-fat diet promoted growth of established human prostate LNCaP tumors in nude mice. J. Urol., 161, 1651-1654.
17. Pathak,S.K., Sharma,R.A. and Mellon,J.K. (2003) Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review). Int. J. Oncol., 22, 5-13.
18. Pollard,M. and Luckert,P.H. (1986) Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats. Cancer Lett., 32, 223-227.
19. Pour,P.M., Groot,K., Kazakoff,K., Anderson,K. and Schally,A.V. (1991) Effects of high-fat diet on the patterns of prostatic cancer induced in rats by N-nitrosobis (2-oxopropyl)amine and testosterone. Cancer Res., 51, 4757-4761.
20. Shirai,T., Yamamoto,A., Iwasaki,S., Tamano,S. and Masui,T. (1991) Induction of invasive carcinomas of the seminal vesicles and coagulating glands of F344 rats by administration of N-methylnitrosourea or N-nitrosobis (2-oxopropyl)amine and followed by testosterone propionate with or without high-fat diet. Carcinogenesis, 12, 2169-2173.
21. Kondo,Y., Homma,Y., Aso,Y. and Kakizoe,T. (1994) Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats. Cancer Res., 54, 6129-6132.
22. Isaacs,J.T. (1984) The aging ACI/Seg versus Copenhagen male rat as a model system for the study of prostatic carcinogenesis. Cancer Res., 44, 5785-5796.
23. Rohan,T., Howe,G., Burch,J. and Jain,M. (1995) Dietary factors and risk of prostate cancer: a case-control study in Ontario, Canada. Cancer Causes Control, 6, 145-154.
24. Eichholzer,M., Stahelin,H., Gutzwiller,F., Ludin,E. and Bernasconi,F. (2000) Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study. Am. J. Clin. Nutr., 71, 569-574.
25. Tagawa,Y., Ozaki,K., Takahashi,S., Ogawa,K. and Shirai,T. (1992) Lack of effects of post-initiation cholesterol on 3,2′-dimethyl-4- aminobiphenyl-induced prostate carcinogenesis. Prostate, 20, 179-185.
26. Nakayama,M., Ju,H.R., Sugano,M., Hirose,N., Ueki,T., Doi,F. and Eynard,A.R. (1993) Effect of dietary fat and cholesterol on dimethylbenz[a]anthracene-induced mammary tumorigenesis in Sprague-Dawley rats. Anticancer Res., 13, 691-698.
27. Klurfeld,D.M., Aglow,E., Tepper,S.A. and Kritchevsky,D. (1983) Modification of dimethylhydrazine-induced carcinogenesis in rats by dietary cholesterol. Nutr. Cancer, 5, 16-25.
28. Wilson,S.H., Best,P.J., Lerman,L.O., Holmes,D.R.,Jr, Richardson,D.M. and Lerman,A. (1999) Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2 alpha, in experimental hypercholesterolemia. Cardiovasc Res., 44, 601-607.
29. Heinle,H., Brehme,U., Friedemann,G., Frey,J.C., Wolf,A.T., Kelber,O., Weiser,D., Schmahl,F.W., Lang,F. and Schneider,W. (2002) Intimal plaque development and oxidative stress in cholesterol-induced atherosclerosis in New Zealand rabbits. Acta Physiol. Scand., 176, 101-107.
30. Morin,R.J., Hu,B., Peng,S.K. and Sevanian,A. (1991) Cholesterol oxides and carcinogenesis. J. Clin. Lab. Anal., 5, 219-225.
31. Yamamoto,Y., Kawamura,M., Tatsuno, Yamashita,S., Niki,E. and Naito,C. (1991) Formation of lipid hydroperoxides in the cupric ion-induced oxidation of plasma and low density lipoprotein. In Davies,K.J.A. (ed.) Oxidative Damage and Repair. Pergamon Press, New York, pp. 287-291.
32. Yamashita,S. and Yamamoto,Y. (1997) Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress. Anal. Biochem., 250, 66-73.
33. Hara,K., Yamashita,S., Fujisawa,A. Ishiwa,S., Ogawa,T. and Yamamoto,Y. (1999) Oxidative stress in newborn infants with and without asphyxia as measured by plasma antioxidants and free fatty acids. Biochem. Biophys. Res. Commun., 257, 244-248.
34. Yamamoto,Y., Yamashita,S., Fujisawa,A., Kokura,S. and Yoshikawa,T. (1998) Oxidative stress in patients with hepatitis, cirrhosis and hepatoma evaluated by plasma antioxidants. Biochem. Biophys. Res. Commun., 247, 166-170.
35. Yamamoto,Y. and Yamashita,S. (1999) Plasma ubiquinone to ubiquinol ratio in patients with hepatitis, cirrhosis and hepatoma and in patients treated with percutaneous transluminal coronary reperfusion. Biofactors, 9, 241-246.
36. Bosland,M.C. (1983) Adenocarcinoma, prostate, rat. In Jones,T.C., Mohr,R.D. and Hunt,R.D. (eds) Monograms on the Pathology of Laboratory Animals. Springer Verlag, Berlin, vol. 5, pp. 252-272.
37. Yamamoto,Y. and Ames,B.N. (1987) Detection of lipid hydroperoxides and hydrogen peroxide at picomole levels by an HPLC and isoluminol chemiluminescence assay. Free Radic. Biol. Med., 3, 359-361.
38. Bowry,V.W., Mohr,D., Cleary,J. and Stocker,R. (1995) Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein. J. Biol. Chem., 270, 5756-5763.
39. Ellis,L. and Nyborg,H. (1992) Racial/ethnic variations in male testosterone levels: a probable contributor to group differences in health. Steroids, 57, 72-75.
40. Homma,Y., Kaneko,M., Kondo,Y., Kawabe,K. and Kakizoe,T. (1997) Inhibition of rat prostate carcinogenesis by a 5alpha-reductase inhibitor, FK143. J. Natl Cancer Inst., 89, 803-807.
41. Ripple,M.O., Henry,W.F., Schwarze,S.R., Wilding,G. and Weindruch,R. (1999) Effect of antioxidants on androgen-induced AP-1 and NF-kappaB DNA-binding activity in prostate carcinoma cells. J. Natl Cancer Inst., 91, 1227-1232.